Severity
Low
FDA Drug recall · Reported May 22, 2013
Subpotent; Cetylpyridinum Chloride
Hi-Tech Pharmacal Co., Inc. recalled BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 mg, Menthol 4… - a low-severity action.
BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 mg, Menthol 4… was recalled by Hi-Tech Pharmacal Co., Inc. in May 22, 2013. Reason: Subpotent; Cetylpyridinum Chloride. Check the official notice for the remedy. Verify recall #D-418-2013 with the FDA Drug before acting.
The recall
Hi-Tech Pharmacal Co., Inc. issued this low-severity FDA Drug recall-Subpotent; Cetylpyridinum Chloride.
Sourced from official FDA Drug enforcement records. Verify recall #D-418-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-418-2013) was formally reported on May 22, 2013, with the manufacturer initiating the action on April 8, 2013. It is classified under Low severity (Class III), with a current status of Terminated. Hi-Tech Pharmacal Co., Inc. is listed as the recalling firm, operating out of Amityville, NY. Federal records list the affected scope as 10,440 bottles.
The documented reason for this recall is: Subpotent; Cetylpyridinum Chloride Distribution data in the federal record shows the product reached: Puerto Rico. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
10,440 bottles
Related Recalls
6
5 from same agency
BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 mg, Menthol 45 mg Zinc Chloride 30 mg), 1 Fl. Oz. (30 mL), Manufactured for GIL PHARMACEUTICAL CORP, PONCE, PUERTO RICO 00717-1565 -- NDC 58552-103-01
Subpotent; Cetylpyridinum Chloride
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-418-2013 |
| Date reported | May 22, 2013 |
| Date initiated | April 8, 2013 |
| Recalling firm | Hi-Tech Pharmacal Co., Inc. |
| Firm location | Amityville, NY |
| Affected scope | 10,440 bottles |
| Distribution | Puerto Rico |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 22, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.